Investigation of Dietary Absorptive Capacity of Fructans in Healthy Subjects - A Dose Response Study
1 other identifier
interventional
19
1 country
1
Brief Summary
Fructan is a carbohydrate polymer that is composed of fructose and a terminal glucose moiety . Fructans are naturally found in artichokes (6.1 grams/serving), leeks (5.9 grams/serving), onion bulbs (1.01 grams/serving), flour (4.0 grams/serving), garlic (.52 grams/serving), watermelon (.92 grams/serving), nectarines (.27 grams/serving) and white peaches (.50 grams/serving). Because fructans are present in many common foods, people typically ingest high levels of fructan. The most common structural forms of fructan are inulin, levanare and geraminan . The human body absorbs only 5% of fructan, however it is estimated that the daily intake in the USA may vary between 1-20 grams, and possibly higher due to the recently discovered benefits of inulins . Dietary trends indicate that high levels of fructans are common in the European and American diet, as more wheat based products such as breakfast cereal, pasta, and bread are consumed. Fructans may not be well tolerated by some subjects and its malabsorption may result in gastrointestinal (GI) symptoms such as heartburn, belching, abdominal pain, diarrhea, gas, and bloating; and this is especially true when higher doses are ingested. Unlike glucose, fructans are not efficiently digested or absorbed by the small intestine. The mechanism for malabsorption is related to the inability to hydrolyze glycosidic linkages in the complex polysaccharide, resulting in the delivery of malabsorbed fructans to the large bowel1. In the colon, the malabsorbed fructans are rapidly fermented, and byproducts of this fermentation include H2, CH4, and other gases that may contribute to bowel symptoms. Furthermore, the small molecular nature of fructans results in an osmotic effect which draws more water into the small intestine and causes bloating and diarrhea. Ingestion of high doses of fructans can cause symptoms in healthy adults, but may cause more bothersome symptoms in subjects with Irritable Bowel Syndrome (IBS). Earlier studies have identified that IBS affects between 10 and 15% of the population in the United States. Ingestion of 10-20 grams of fructan daily may cause symptoms of IBS, and restricting fructan intake in a diet may reduce symptoms in a variety of gastrointestinal disorders. One study recently published found that dietary restriction of fructan and fructose was responsible for symptomatic improvement in patients with IBS. Hypothesis: The investigators hypothesize that healthy individuals will absorb fructan 7.5 gram and 10 gram doses, and will experience malabsorption at the 12.5 gram fructan dose.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy-volunteers
Started Jun 2009
Longer than P75 for not_applicable healthy-volunteers
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
September 22, 2009
CompletedFirst Posted
Study publicly available on registry
October 2, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2018
CompletedJuly 23, 2018
July 1, 2018
2.2 years
September 22, 2009
July 20, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Hydrogen and Methane Concentration levels
Measure breath sample concentration for hydrogen and methane levels in parts per million
3 visits over a 1 month period
Secondary Outcomes (1)
Production of GI Symptoms
3 visits over a 1 month period
Study Arms (4)
Fructan - 7.5
EXPERIMENTALSubjects will consume 7.5 grams of fructan
Fructan - 10 grams
EXPERIMENTALSubjects will consume 10 grams of fructan
Fructan - 12.5 grams
EXPERIMENTALSubjects will consume 12.5 grams of fructan
5 grams Fructan
EXPERIMENTALExperimental - 5 grams Fructan Subjects will consume 5 grams of Fructan.
Interventions
Subjects will consume 7.5 grams of fructan
Subjects will consume 10 grams of fructan
Subjects will consume 12.5 grams of fructan
Subjects will consume 5 grams fructan.
Eligibility Criteria
You may qualify if:
- Healthy volunteers between the ages of 18-70 years, with no previous history of gastrointestinal problems or any other ailments, no history of gastrointestinal surgery except appendectomy, cholecystectomy, caesarean section, hysterectomy and currently not using any medication except contraceptive pill, multivitamin, or aspirin.
- They will be asked to fill out a Review of Systems health history (Appendix 2) and the Mayo Clinic Bowel Disease Questionnaire (Appendix 3) and will undergo a routine physical examination. Only patients who are asymptomatic and deemed healthy from the aforementioned screening procedure will be eligible.
You may not qualify if:
- Currently taking medication for any ailment including OTC medication (excluding aspirin, multivitamins, and oral contraceptives)
- History of gastrointestinal problems including bloating, gas, food intolerances or reflux symptoms
- Any major abdominal surgery (except appendectomy, cholecystectomy, caesarean section, hysterectomy) or coexisting medical problem
- Known food allergies
- Prisoners
- Cognitive Impairment or any other inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Satish Rao, MD, PhD
Augusta University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 22, 2009
First Posted
October 2, 2009
Study Start
June 1, 2009
Primary Completion
August 31, 2011
Study Completion
July 20, 2018
Last Updated
July 23, 2018
Record last verified: 2018-07